Prevalence is an important high-level population-health indicator of the burden of cancer.

Survival from cancer varies depending on many factors, such as demographic characteristics, tumour type, stage of the cancer at diagnosis, co-morbidities, other prognostic indic

Survival from cancer can be influenced by various factors including demographic characteristics, tumour type, stage of the cancer at diagnosis, other prognostic indicators, and

Cancer incidence data, as presented in this report, refer to the number of new cases of cancer diagnosed each year. They can be presented as absolute numbers or as rates.

Cancer mortality data, as presented, refer to the number of deaths in a calendar year for which the underlying cause is cancer.

The MIR is a crude indicator of case fatality of a selected cancer.

This measure shows the number of people receiving at least one of the cancer-related systemic therapies and a small number of supportive treatments in Australia in any one year

The measure "Radiotherapy treatment activity" presents data for radiotherapy services delivered in Australia between 2013 and 2015, as indicated by reimbursement claims under th

This measure presents national survival by stage at diagnosis data for prostate cancer in Australia using data sources that are routinely accessible to all cancer registries.